Hubert Erich Blum

Hubert Erich Blum's AcademicInfluence.com Rankings

Hubert Erich Blum

Philosophy

#5196

World Rank

#7933

Historical Rank

Logic

#2514

World Rank

#3518

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Hubert Erich Blum's Degrees

Doctorate Medicine University of Zurich
PhD Medical Sciences University of Zurich

Why Is Hubert Erich Blum Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Hubert Erich Blum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. (2003) (966)
Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex (2002) (943)
Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons (2003) (696)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C (2007) (558)
Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* (2003) (531)
p53 mutation in hepatocellular carcinoma after aflatoxin exposure (1991) (478)
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. (2000) (477)
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis (2001) (444)
T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection (2005) (438)
An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* (2002) (387)
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation (2010) (381)
The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. (1995) (354)
A lymphotoxin-driven pathway to hepatocellular carcinoma. (2009) (350)
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties (2010) (341)
Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines (2000) (340)
Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway (1999) (313)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A* (2004) (305)
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors. (2007) (299)
Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes (2004) (286)
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 (2007) (280)
Malignant ascites: systematic review and guideline for treatment. (2006) (273)
Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma (2014) (272)
Detection of Viral Nucleic Acids by in Situ Hybridization (1984) (270)
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. (2001) (266)
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis (2001) (246)
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase* (2001) (244)
Hepatocellular carcinoma: therapy and prevention. (2005) (243)
Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo (1996) (232)
Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution (2006) (224)
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). (1990) (219)
Primary hepatocellular carcinoma. (1991) (210)
Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction (2006) (202)
The molecular biology of hepatitis B virus. (1989) (201)
Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection (2006) (201)
Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. (2003) (190)
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia (2002) (188)
Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication (2004) (181)
Pathogenesis of hepatocellular carcinoma. (2005) (177)
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis (1994) (175)
Intrahepatic CD8+ T‐cell failure during chronic hepatitis C virus infection (2005) (173)
Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients (2001) (171)
Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation (2005) (171)
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins (1998) (163)
Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. (2003) (162)
Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. (1983) (160)
Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference (2009) (158)
Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41. (2008) (157)
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26) (2012) (154)
Hepatitis B virus X protein is not central to the viral life cycle in vitro (1992) (153)
The human microbiome. (2017) (153)
Efficient Infection of Primary Tupaia Hepatocytes with Purified Human and Woolly Monkey Hepatitis B Virus (2001) (153)
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication (1991) (153)
Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma (1999) (151)
APOBEC‐mediated interference with hepadnavirus production (2005) (144)
T cell response in hepatitis C virus infection. (2005) (138)
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex (2008) (138)
Hepatitis C virus-induced hepatocarcinogenesis. (2009) (137)
Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis (2000) (136)
Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver (2006) (135)
Do religious or spiritual beliefs influence bereavement? A systematic review (2007) (135)
Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. (1995) (134)
Virological and immunological determinants of intrahepatic virus‐specific CD8+ T‐cell failure in chronic hepatitis C virus infection (2008) (134)
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. (2009) (128)
Clinical Interpretation and Implications of Whole Genome Sequencing (2014) (125)
Hepatitis C virus infection and apoptosis. (2007) (124)
Hepatitis B virus infection in patients with idiopathic liver disease (1991) (124)
Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner (2010) (124)
Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers (1990) (122)
[Molecular virology of hepatitis C]. (2002) (122)
Molecular pathogenesis of colorectal cancer (2005) (122)
Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy (2012) (121)
The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment (2002) (117)
Long‐acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double‐blind study (2007) (117)
HBV life cycle and novel drug targets (2011) (117)
Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus (2009) (116)
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. (1982) (114)
Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection—a single‐center analysis including 132 patients (1998) (113)
An error model for protein quantification (2007) (112)
Neurological manifestations of chronic hepatitis C (1999) (112)
Activation of dendritic cells by local ablation of hepatocellular carcinoma. (2005) (108)
Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. (2002) (107)
Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection (1991) (106)
Does hepatitis C virus cause hepatocellular carcinoma? (1994) (106)
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. (2005) (106)
Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. (2000) (106)
EGFR and HER2 expression in advanced biliary tract cancer. (2008) (105)
Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of Primary Tupaia Hepatocytes (2005) (104)
Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines (2002) (100)
MOLECULAR PATHOGENESIS OF HEPATITIS B VIRUS INFECTION: SIMULTANEOUS DETECTION OF VIRAL DNA AND ANTIGENS IN PARAFFIN-EMBEDDED LIVER SECTIONS (1984) (100)
Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion. (2008) (100)
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (2008) (99)
Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B (2009) (98)
Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. (2009) (96)
Correlation of duplex sonography findings and portal pressure in 375 patients with portal hypertension. (1999) (93)
Molecular Virology of Hepatitis C Virus (HCV): 2006 Update (2006) (92)
Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G" (2004) (91)
Cyclin D1 overexpression and p53 inactivation immortalize primary oral keratinocytes by a telomerase-independent mechanism. (2001) (91)
Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review. (2007) (89)
Hepatitis B Virus Nucleocapsids Formed by Carboxy-Terminally Mutated Core Proteins Contain Spliced Viral Genomes but Lack Full-Size DNA (2004) (86)
Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. (2008) (85)
Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C (2000) (83)
Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C (2004) (83)
New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication (2009) (82)
Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. (2000) (82)
A sphincterotome-based technique for selective transpapillary common bile duct cannulation. (2000) (82)
Parallel Expansion of Human Virus-Specific FoxP3− Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro1 (2007) (80)
Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes (2003) (78)
Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. (2005) (76)
Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase gene (2000) (75)
Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. (2000) (74)
T-cell responses in hepatitis B and C virus infection: similarities and differences (2013) (73)
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors. (2009) (72)
A simple and rapid method for the detection of RNA in formalin-fixed, paraffin-embedded tissues by PCR amplification. (1991) (71)
Serum markers of hepatocellular carcinoma. (2006) (71)
Targeted therapy for hepatocellular carcinoma (2009) (70)
Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. (1998) (69)
Hepatitis B Viral Nucleotide Sequences in Non‐A, Non‐B or Hepatitis B Virus‐Related Chronic Liver Disease (1984) (69)
Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template. (1992) (69)
Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver (2008) (67)
Analysis of CD8+ T cell-mediated inhibition of hepatitis C virus replication using a novel immunological model (2009) (67)
Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. (1985) (67)
Natural history of restricted synthesis and expression of measles virus genes in subacute sclerosing panencephalitis. (1985) (66)
Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. (1984) (65)
Comprehensive analysis of the α‐fetoprotein‐specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (65)
T Cells with a CD 4 CD 25 Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD 8 T Cells during Chronic Hepatitis C Virus Infection (2005) (64)
Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma (2012) (64)
Acute hemoperitoneum after large-volume paracentesis. (1997) (63)
End-of-life care in hospital: current practice and potentials for improvement. (2007) (62)
Slow virus visna: reproduction in vitro of virus from extrachromosomal DNA. (1984) (62)
Creating oral squamous cancer cells: A cellular model of oral–esophageal carcinogenesis (2005) (61)
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype‐specific immunodominant CD8+ T‐cell epitope (2010) (61)
[DNA vaccination]. (2000) (60)
Immunodominance of HLA-A2-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses Is Linked to Naïve-Precursor Frequency (2011) (58)
Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis (2002) (58)
Hepatitis C: molecular virology and antiviral targets. (2002) (58)
Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase* (2002) (56)
Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice. (2001) (55)
Cellular retinol‐binding protein‐1 in hepatocellular carcinoma correlates with β‐catenin, Ki‐67 index, and patient survival (2003) (55)
Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes (2005) (54)
Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine (2008) (54)
A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. (1998) (54)
The transcription factor c‐Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival (2012) (53)
Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner1 (2008) (53)
DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study (2009) (52)
Four minutes for a patient, twenty seconds for a relative - an observational study at a university hospital (2010) (51)
Platelet aggregation and platelet‐derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: A randomized study comparing trapidil plus ticlopidine with heparin treatment (1999) (51)
Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro‐entero‐pancreatic system (2007) (51)
Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. (2007) (50)
Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. (2005) (50)
Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system. (2006) (50)
Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry (2006) (49)
EGFR overexpression induces activation of telomerase via PI3K/AKT‐mediated phosphorylation and transcriptional regulation through Hif1‐alpha in a cellular model of oral–esophageal carcinogenesis (2011) (49)
Tuberculous colitis mimicking Crohn's disease (1998) (49)
Central Role of a Serine Phosphorylation Site within Duck Hepatitis B Virus Core Protein for Capsid Trafficking and Genome Release* (2003) (49)
Ongoing Murine T1 or T2 Immune Responses to the Hepatitis B Surface Antigen Are Excluded from the Liver that Expresses Transgene-Encoded Hepatitis B Surface Antigen1 (2000) (48)
Molecular characteristics and predictors of survival in patients with malignant neuroendocrine tumors (2008) (48)
Cytokine and hepatitis B virus DNA Co‐immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice (1998) (48)
Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs (2007) (48)
Inhibition of hepatitis B virus by antisense oligodeoxynucleotides (1991) (48)
Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. (2008) (47)
Palliative cancer care: an epidemiologic study. (2011) (47)
Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti‐MDR1 ribozymes (2002) (47)
Viral pathogenesis of hepatocellular carcinoma (2002) (47)
Trypsinogen Gene Mutations in Patients with Chronic or Recurrent Acute Pancreatitis (2001) (46)
Selective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B (1995) (46)
Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice. (2001) (46)
Hepatitis B virus: significance of naturally occurring mutants. (1993) (43)
Rapid and simple detection of IFN‐neutralizing antibodies in chronic hepatitis C non‐responsive to IFN‐α (2006) (43)
Renal grafts from anti‐hepatitis B core‐positive donors: a quantitative review of the literature (2012) (42)
Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. (1995) (42)
Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. (2013) (42)
Current and evolving therapies for hepatitis C. (1999) (42)
The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice (2013) (41)
Conserved Determinants for Membrane Association of Nonstructural Protein 5A fromHepatitis C Virus and Related Viruses (2006) (41)
Prognostic Relevance of Carbohydrate Antigen 19-9 Levels in Patients with Advanced Biliary Tract Cancer (2007) (40)
Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. (1998) (40)
[DNA chip technology]. (1999) (40)
Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro (2001) (38)
Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma. (2004) (36)
CD117 (c-kit) expression in human hepatocellular carcinoma. (2007) (35)
Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. (1985) (35)
Spot‐blot hybridization assay for the detection of hepatitis b virus dna in serum: Factors determining its sensitivity and specificity (1987) (34)
Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro (2001) (34)
Hepatitis B or hepatitis C and human immunodeficiency virus infection. (2005) (34)
Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection (2009) (33)
Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. (2000) (33)
Coordinated expression of cyclin D1 and LEF‐1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma (2005) (32)
Duck Hepatitis B Virus Nucleocapsids Formed by N-Terminally Extended or C-Terminally Truncated Core Proteins Disintegrate during Viral DNA Maturation (1998) (32)
The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes. (2004) (31)
A primer on the molecular virology of hepatitis C (2004) (31)
CD161+CD4+ T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ (2012) (31)
Molecular Targets for Prevention of Hepatocellular Carcinoma (2002) (31)
CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients (2009) (30)
Functional Analysis of Claudin-6 and Claudin-9 as Entry Factors for Hepatitis C Virus Infection of Human Hepatocytes by Using Monoclonal Antibodies (2013) (30)
Phosphodiesterase 5 inhibitors lower both portal and pulmonary pressure in portopulmonary hypertension: a case report (2007) (29)
Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha. (2006) (29)
Immunotherapy directed against α-fetoprotein results in autoimmune liver disease during liver regeneration in mice (2001) (29)
Inhibition of duck hepatitis B virus infection by lysosomotropic agents. (1991) (29)
Acute Mycoplasma pneumoniae Infection Presenting as Cholestatic Hepatitis (2003) (28)
Toll-Like Receptor 2 Senses Hepatitis C Virus Core Protein but Not Infectious Viral Particles (2009) (28)
Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide (2011) (28)
Gene therapy for malignant liver disease (2002) (28)
Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication. (1998) (27)
Hepatocellular carcinoma in alcoholic liver disease: No evidence for a pathogenetic role of hepatitis B virus infection (1988) (27)
Intracellular Retention of Hepatitis B Virus Surface Proteins Reduces Interleukin-2 Augmentation after Genetic Immunizations (1999) (27)
Rapid Antigen Processing and Presentation of a Protective and Immunodominant HLA-B*27-restricted Hepatitis C Virus-specific CD8+ T-cell Epitope (2012) (26)
Nucleic acid‐based antiviral and gene therapy of chronic hepatitis B infection (1997) (26)
DDB treatment of patients with chronic hepatitis (2004) (26)
Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes (2005) (26)
Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis (1999) (26)
Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. (2007) (26)
Combined macroscopic and microscopic detection of viral genes in tissues. (1985) (26)
Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression. (2008) (25)
[Treatment of hepatocellular carcinoma]. (2005) (25)
Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon γ-producing CD8(+) T cells during chronic infection. (2012) (25)
Molecular therapy and prevention of hepatocellular carcinoma. (2003) (25)
Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. (2001) (25)
Hepatitis B virus infection. Current concepts of chronicity and immunity. (1984) (25)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5 A (2004) (25)
Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro (2015) (24)
Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver (2009) (24)
Lack of ex vivo peripheral and intrahepatic α‐fetoprotein‐specific CD4+ responses in hepatocellular carcinoma (2011) (24)
Scavenger Receptor BI Is a Key Host Factor for Hepatitis C Virus Infection Required for an Entry Step Closely Linked to CD 81 (2009) (24)
Induction of autoimmune phenomena in patients with chronic hepatitis B treated with gamma-interferon. (1994) (24)
Locoregional therapy for cholangiocarcinoma (2013) (24)
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation (2009) (24)
Duck hepatitis B virus: DNA polymerase and reverse transcriptase activities of replicative complexes isolated from liver and their inhibition in vitro. (1988) (23)
[Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases]. (1999) (23)
Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154. (2010) (23)
Environment and Life Style - Effects on Disorders of the Digestive Tract (2010) (23)
Suramin prevents duck hepatitis B virus infection in vivo (1993) (22)
Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands (2012) (22)
Immunobiology and gene-based immunotherapy of hepatocellular carcinoma. (2003) (22)
Evolving therapies in the treatment of hepatocellular carcinoma (2008) (22)
Fatal esophagoaortic fistula after placement of a self-expanding metal stent in a patient with esophageal carcinoma. (1997) (21)
Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. (2011) (21)
Host cell responses induced by hepatitis C virus binding (2006) (21)
Hepatocellular carcinoma: an update. (2007) (21)
History and Global Burden of Viral Hepatitis (2016) (21)
GRAND ROUNDS IN RHEUMATOLOGY EDITED BY D. L. SCOTT SUCCESSFUL TREATMENT OF GASTROINTESTINAL VASCULITIS DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS WITH INTRAVENOUS PULSE CYCLOPHOSPHAMIDE: A CLINICAL CASE REPORT AND REVIEW OF THE LITERATURE (1998) (21)
Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. (1992) (21)
Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications. (2001) (21)
Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. (2001) (20)
CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway (2013) (20)
Tetramer Enrichment Reveals the Presence of Phenotypically Diverse Hepatitis C Virus-Specific CD8+ T Cells in Chronic Infection (2014) (19)
Hepatitis C Virus RNA Replication Requires a Conserved Structural Motif within the Transmembrane Domain of the NS5B RNA-Dependent RNA Polymerase (2010) (19)
Identification of two separable modules in the duck hepatitis B virus core protein (1995) (19)
Colorectal cancer: future population screening for early colorectal cancer. (1995) (19)
Selenium levels in patients with hepatitis C virus‐related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: A pilot study (2013) (18)
Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. (2012) (18)
Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice. (2001) (18)
Immunotherapy directed against alpha-fetoprotein results in autoimmune liver disease during liver regeneration in mice. (2001) (17)
Genetic variants of hepatitis B virus and their clinical relevance. (2005) (17)
Optimal management of emergent hypertension during treatment with a VEGF signaling inhibitor: A randomized phase II study of cediranib (2008) (17)
Hepatitis C update (2001) (16)
Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis. (2005) (16)
Human transmissible spongiform encephalopathies. (1998) (16)
The hepatitis C virus NS5A protein and response to interferon α: mutational analyses in patients with chronic HCV genotype 3a infection from India (2007) (15)
Human non-hepatocytes support hepadnaviral replication and virion production. (1992) (15)
The Transcription Factor c-Jun Protects against Liver Damage following Activated β-Catenin Signaling (2012) (15)
Laboratory diagnosis of hepatitis B virus infection by nucleic acid hybridization analyses and immunohistologic detection of gene products. (1985) (15)
Antisense therapy of hepatitis B virus infection (1998) (15)
Hypermutation of hepatitis B virus genomes by APOBEC 3 G , APOBEC 3 C and APOBEC 3 H (2008) (15)
VEGF Trap for the treatment of malignant ascites. (2012) (14)
Advances in prevention and diagnosis of hepatocellular carcinoma (2008) (14)
1243 Octreotide treatment in patients with advanced hepatocellular carcinoma: first results of the randomized placebo-controlled double-blind Hector trial (2003) (14)
Identification and functional characterization of the putative polysaccharide biosynthesis protein (CapD) of Enterococcus faecium U0317. (2016) (14)
An Aminoterminal Amphipathic-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5 A (2001) (14)
Hepatitis B and C virus and alcohol‐induced liver injury (1991) (14)
Ampullary Hamartoma: A Rare Cause of Biliary Obstruction (1999) (14)
Molecular biology and gene therapy in gastroenterology and hepatology. (1999) (14)
Characterization of Nonstructural Protein Membrane Anchor Deletion Mutants Expressed in the Context of the Hepatitis C Virus Polyprotein (2005) (13)
Hepatocellular carcinoma (HCC) (2011) (13)
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo (1996) (13)
Duck hepatitis B virus infection of non-hepatocytes. (2008) (13)
HEPATITIS B VIRUS IN NON-HEPATOCYTES (1983) (13)
Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81. (2009) (13)
[Therapy of chronic hepatitis C]. (2006) (13)
Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection. (2009) (13)
Analysis of molecular pathways in neuroendocrine cancers of the gastroenteropancreatic system. (2015) (13)
Hepatitis viruses: genetic variants and clinical significance (1997) (12)
Transport of heptafluorostearate across model membranes. Membrane transport of long-chain fatty acid anions I. (2000) (12)
Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma. (1986) (12)
Theoretical and Experimental Selection Parameters for HBV-Directed Antisense RNA Are Related to Increased RNA-RNA Annealing (1997) (12)
Sulfated polyanions do not inhibit duck hepatitis B virus infection (1991) (11)
61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATION (2008) (11)
[Parietal cell antibodies in primary biliary cirrhosis: pathogenetic or diagnostic significance?]. (1994) (11)
Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides (2005) (10)
Molecular therapy and prevention of liver diseases (2008) (10)
Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAg (2008) (10)
Orthotopic liver transplantation in hemophilia B: a case report (1995) (10)
[Ulcerous colitis and infection with cytomegalovirus, herpes simplex virus and clostridium difficile]. (2008) (10)
Radiofrequency Thermal Ablation of Hepatocellular Carcinoma (2002) (10)
[Therapy of chronic hepatitis]. (2008) (9)
HCV RNA in patients with chronic hepatitis C treated with interferon‐α (1993) (9)
Cis‐preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex (2002) (9)
Advances in individualized and regenerative medicine. (2014) (9)
Analysis of Molecular Pathways in Neuroendocrine Cancers of the Gastroenteropancreatic System (2004) (9)
[Diagnosis, progression and therapy of hepatitis-B-virus infection--results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network]. (2004) (9)
Platelet count to spleen diameter ratio non‐invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis (2016) (9)
Polymerase chain reaction analysis of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver biopsies from alcoholics using a simplified and standardized amplification protocol. (1994) (8)
A Mouse Model of Oral-Esophageal Carcinogenesis (2004) (8)
HEPATOCELLULAR CARCINOMA: AN UPDATE HUBERT E (2007) (8)
402 Viral and cellular determinants of hepatitis c virus envelope-heparan sulfate interaction (2006) (8)
Therapy of hepadnavirus infection using antisense oligonucleotides. (1995) (8)
[Percutaneous treatment of liver tumors using interstitial radiofrequency thermoablation. A new therapeutic strategy]. (2008) (8)
[Recurrent bleeding from colonic varices in portal hypertension. The successful prevention of recurrence by the implantation of a transjugular intrahepatic stent-shunt (TIPS)]. (1995) (8)
Independent regulation of two separate gene activities in a continuous human cell line. (1998) (8)
A novel target of hepatitis B virus mutations: Splicing of surface RNA (2005) (7)
[Hepatitis B virus mutants--clinical significance]. (1997) (7)
Gene therapy: basic concepts and applications in gastrointestinal diseases. (1997) (7)
Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report. (2005) (7)
Recent developments in target identification against hepatitis C virus (2004) (7)
Biological efficacy and signal transduction through STAT proteins of recombinant duck interferon in duck hepatitis B virus infection. (1998) (6)
[Diagnosis of hepatitis B and C]. (2005) (6)
[Eosinophilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid]. (1994) (6)
Increasing the collaboration between human and animal medicine: an effort of the Federation of European Academies of Medicine (FEAM) (2012) (6)
[Therapy of hepatocellular carcinoma]. (1996) (6)
The influence of tips on portal hemodynamics and liver function with respect to hepatic encephalopathy and survival (1995) (6)
Psychosomatic liaison service in medicine - need for psychotherapeutic interventions and their realisation. (2002) (6)
Human Hepatitis B Virus Production in Avian Cells Is Characterized by Enhanced RNA Splicing and the Presence of Capsids Containing Shortened Genomes (2012) (6)
Genetic predisposition for alcohol-associated upper aerodigestive tract cancer and hepatocellular carcinoma in heavy drinkers with the alcohol dehydrogenase 3*1 allele (2003) (6)
Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Post-Binding Steps and Membrane Fusion (2008) (6)
[Diagnosis of hepatocellular carcinoma]. (1996) (5)
Of mice and men: A small animal model of hepatitis C virus replication (2002) (5)
[Trans-jugular intrahepatic portosystemic stent-shunt (TIPS) in a patient with Budd-Chiari syndrome]. (1993) (5)
Hypothyroidism in patients with hepatocellular carcinoma treated by transarterial chemoembolization (2008) (5)
Screening for hepatocellular carcinoma by Egyptian physicians. (2015) (5)
Detection and characterization of bacterial polysaccharides in drug-resistant enterococci (2019) (5)
[Hepatology 2009]. (2009) (5)
Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo. (1996) (5)
Hepatocellular carcinoma: susceptibility markers. (2001) (5)
Tracking cccDNA in chronic HBV infection (2004) (5)
Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins. (2005) (5)
Comprehensive analysis of the α-Fetoprotein specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (5)
Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells. (2008) (5)
The Microbiome: a Key Player in Human Health and Disease (2017) (5)
Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection (2011) (5)
Heptitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions (1995) (4)
Weight loss and severe jaundice in a patient with hyperthyroidism. (2011) (4)
Frequency of celiac disease in Egyptian patients with chronic diarrhea: Endoscopic, histopathologic and immunologic evaluation (2011) (4)
[Procedures for problematic situations with hepatitis B]. (2004) (4)
[Hemosuccus pancreaticus--a rare cause of upper gastrointestinal bleeding. Successful treatment in two cases by radiologic-interventional embolization of the splenic artery]. (2008) (4)
[A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide]. (2000) (4)
Cell lines that allow regulated expression of HCV proteins: principles and applications (2003) (4)
[Genome-wide association studies]. (2011) (4)
Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
Hepatitis C: a concise review. (2001) (4)
Non-A, non-B hepatitis: a contemporary assessment. (1982) (4)
617 E1 therapeutic vaccination in patients with chronic HCV genotype 1 infection: Results of a 15-month, placebo-controlled trial (2006) (4)
[Hepatosplenic schistosomiasis: case report and clinical review]. (1993) (4)
The Human Microbiome: An Emerging Key Player in Health and Disease (2017) (4)
[Liver diseases in pregnancy]. (2008) (3)
[Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods]. (2004) (3)
NATURAL COURSE OF HBV INFECTION (1998) (3)
[Tyrosine kinase inhibitors in tumor therapy--part 1. Molecular and genetic fundamentals]. (2005) (3)
[Hepatology 2010]. (2010) (3)
Out of control: hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma. (2004) (3)
Transarterial chemoembolization of intrahepatic cholangiocarinoma with irinotecan-eluting beads: preliminary results (2009) (3)
[Clinical significance of hepatitis B virus mutants]. (1998) (3)
Antiviral therapy of hepatitis B virus infection: Blocking viral gene expression (1995) (3)
Appraisal and prospects of a dimeric synthetic peptide coupled with tetanus toxoid for a bifunctional vaccine against hepatitis B virus infection. (1983) (3)
[Therapy of hepatitis B]. (2006) (3)
[Duplexsonography of the liver: state-of-the-art and perspectives]. (2006) (3)
[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection]. (2004) (3)
[Nosocomial diarrhea]. (2001) (3)
Endoscopic therapy of gallstones ileus. (2008) (3)
[The hepatocellular carcinoma: alternative therapeutical strategies]. (2007) (3)
[Hepatocellular carcinoma. Pathogenesis and multicentricity]. (2003) (2)
[Direct antiviral treatment strategies in chronic hepatitis C]. (2012) (2)
Acute hepatitis after autologous stem cell transplantation and rapid progression to liver cirrhosis. (2010) (2)
[Percutaneous liver biopsy]. (2007) (2)
Original articleSelective transmission of variant genomes from mother to infant in neonatal fulminant hepatitis B (1995) (2)
[Systems biology]. (2007) (2)
A severe case of odynophagia (2011) (2)
[Vasculitis and liver disease]. (2006) (2)
[T-cell response against viruses. A new non-cytotoxic antiviral strategy]. (2009) (2)
337 MXA gene expression as a sensitive marker for IFN bioactivity and neutralizing antibodies in chronic hepatitis C virus infection (2003) (2)
[Biology of hepatitis B virus: molecular analyses and clinical relevance]. (1985) (2)
Gastrointestinal and liver diseases: genetic and epigenetic markers (2011) (2)
[Genetic variants of hepatitis B virus and their clinical significance]. (1992) (2)
[Hepatocellular carcinoma: npn-surgical treatment]. (1998) (2)
[A patient with chronic diarrhoe, head pigmentation and alopecia. Cronkhite-Canada syndrome]. (2010) (2)
Colorectal cancer: molecular pathogenesis (2005) (2)
the existence of different memory T cell subsets in the peripheral blood and liver 2 3 (2006) (2)
Molecular therapeutic strategies in hepatitis B virus infection (1994) (2)
Immunobiology of the hepatocellular carcinoma associated tumor antigen alpha-fetoprotein (2003) (2)
The role of Epigenetics in Cancer (2002) (2)
[Acute hepatitis C. Therapy with interferon alpha-2b]. (2002) (2)
Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver. (1997) (2)
[T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma]. (2002) (2)
Chronic cholestatic liver diseases (2002) (2)
FIMS Position Statement 2009 Acute and chronic hepatitis and sports (2)
[Colon cancer: molecular pathogenesis and clinical relevance]. (2005) (2)
Granulocyte colony‐stimulating factor (G‐CSF) may stimulate HIV‐replication during cytostatic chemotherapy (1998) (2)
Update hepatitis A-G. (1997) (2)
[Bacterial infections following sclerosing therapy for esophageal varices]. (1993) (2)
The protective effect of HLA-B27 in hepatitis C virus infection requires presence of a genotype-specific immunodominant CD8+ T cell epitope (2009) (2)
Is Sorafenib an acceptable treatment possibility for patients with advanced hepatocellular carcinoma (2012) (2)
[Epigenetics: significance for tumor genesis and clinical features]. (2002) (1)
Peripherally acting opioid antagonists in the treatment of opiate-related constipation: A systematic review (2008) (1)
[Colon carcinoma: molecular diagnosis and therapy]. (1997) (1)
Individualized medicine 2010 (2010) (1)
[Jaundice in an HIV-positive pregnant woman]. (2008) (1)
Virushepatitis A–E (2006) (1)
[Screening for prevention and early detection of colorectal carcinoma]. (2000) (1)
[Therapeutic monoclonal antibodies]. (2000) (1)
Differenzial functional enhancement of HBV-specific CD8+ T cell upon inhibitory receptor blockade (2013) (1)
[The evaluation of HepatoConsult, a hepatological expert system--the initial results and trends]. (2008) (1)
Functional Mapping of Hepatitis C Virus Envelope-Heparan Sulfate Interaction (2005) (1)
Virus-host interactions during hepatitis C virus entry — implications for pathogenesis and novel treatment approaches (2008) (1)
Hypothyroidism, Congenital (2005) (1)
[Regional therapy of liver tumors]. (2007) (1)
[Immunotherapy of hepatocellular carcinoma]. (2001) (1)
Hepatitis G virus infection in Chinese patients with chronic hepatitis B, C or non-A-E: clinical and molecular aspects (1999) (1)
Comparable effects of Sildenafil, Vardenafil, and Tadalafil – the three licensed inhibitors of phosphodiesterase 5– on portal haemodynamics (2006) (1)
Transjugular intrahepatic portosystemic shunt (TIPS) for treatment of hepatic hydrothorax: Long-term results in 40 patients (2000) (1)
Bridge over troubled water: Protection against hepatitis C virus persistence? (2002) (1)
[Hepatopulmonary syndrome]. (1998) (1)
Gastroenterology Yesterday — Today — Tomorrow: A Review and Preview (2005) (1)
[Seizures following Billroth II gastrectomy]. (2005) (1)
[Hereditary liver diseases]. (2004) (1)
[Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives]. (2005) (1)
Structure and function of the membrane domain of hepatitis C virus nonstructural protein 5A (2004) (1)
[Molecular medicine--personalized medicine. Principles and state-of-the-art]. (2005) (1)
[Cellular immune response in Hepatitis C infection: role of CD154 expression and clinical relevance]. (2011) (1)
[Molecular aspects of hepatocellular carcinoma]. (2000) (1)
Hierarchy of inhibitory receptor expression by Hepatitis B Virus (HBV)-specific CD8+ T cells in chronic HBV infection (2012) (1)
[Best supportive care of hepatocellular carcinoma]. (2004) (1)
Antiviral treatment of patients with HBV‐related cirrhosis (2002) (1)
Molecular diagnosis of microbial infections. (1996) (1)
Acute and chronic hepatitis and sports : FIMS Position Statement 2009 (2009) (1)
Hepatitis B virus infection (1988) (1)
Inhibition of telomerase by mutant template telomerase RNA and anti-telomerase short interfering RNA induces ALT in immortalized human esophageal epithelial cells (2006) (1)
Diagnostik der Hepatitis B und C (2005) (1)
Antisense oligonucleotide therapy of hepadnavirus infection. (2000) (1)
[Chologenic abscess after radiofrequency ablation of a cholangiocellular carcinoma]. (2003) (1)
Dominance of cytolytic effector functions in hepatitis B virus-specific CD8+ T cell and NK cell mediated antiviral efficacy using hepatitis B virus infected hepatocytes overexpressing human sodium taurocholate cotransporting polypeptide (2014) (1)
Local thrombolytic treatment of acute, non-cirrhotic portal vein thrombosis using a transjugular approach (2000) (1)
[Elevated liver enzymes of unknown etiology]. (1994) (1)
[Palliative medicine content in German-language medical textbooks]. (2007) (1)
IL28B genotype and hepatitis C virus specific T cell response (2011) (1)
Antisense therapy of hepatitis B virus infection : in vivo analyses in the duck hepatitis B virus model. (1996) (1)
Capillaria philippinensis: a cause of chronic diarrhea in Upper Egypt (2012) (1)
[A rare cause of an indistinct liver lesion in an elderly woman]. (2011) (1)
Die perkutane Leberbiopsie (2007) (1)
The Intestinal Microbial Community and Inflammatory Bowel Diseases (2017) (1)
Hepatitis C Virus Structural Proteins and Activation of Toll-like Receptor 2 and 4 (2005) (1)
[Hepatitis C, diagnosis and therapy]. (1996) (1)
T-Zell-Antwort gegen Viren – Eine neue nicht-zytotoxische antivirale Strategie (2009) (1)
Effect of intraportal BQ-123, a endothelin rezeptor-a inhibitor, on portal pressure in patients receiving a transjugular intrahepatic portosystemic shunt: Comparison with propranolol and glycylpressin (2000) (1)
Assessment of Liver Function (1998) (1)
Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MRP2 antisense constructs (2004) (1)
Large hepatocellular carcinoma: Treatment with percutaneous radiofrequency thermal ablation after occlusion of tumor blood supply (2000) (1)
[Esophageal carcinoma: non-surgical therapy]. (2004) (1)
Global Epidemiology of Acute Viral Hepatitis A–E (2019) (1)
607 NEUTRALIZING HOST RESPONSES IN HEPATITIS C VIRUS INFECTION TARGET VIRAL ENTRY AT POST-BINDING STEPS AND MEMBRANE FUSION (2008) (1)
[Colon cancer: molecular markers]. (2005) (1)
[From skin to pluripotent stem cells: reprogramming of adult somatic cells]. (2007) (1)
Hepatitis B: diagnosis and management (2021) (1)
[Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation]. (2000) (1)
Mouse α-fetoprotein specific DNA-based immunotherapy of hepatocellular carcinoma to tumor regression in mice (2000) (1)
[Chronic hepatitis B]. (2008) (1)
Akute Hepatitis C Therapie mit Interferon α-2b (2002) (1)
Antigen Transgene-Encoded Hepatitis B Surface Are Excluded from the Liver that Expresses Responses to the Hepatitis B Surface Antigen Ongoing Murine T 1 or T 2 Immune (2000) (1)
[Hepatocellular carcinoma]. (2005) (1)
1252 Homozygosity for the alcoholdehydrogenase 3*1 allele is associated with hepatocellular carcinoma in alcohol-induced cirrhosis (2003) (0)
[Chronic hepatitis C virus infection: always treat!--Contra]. (2002) (0)
Caspase 9-Dependent Manner Hepatocytes to TRAIL-Induced Apoptosis in a Hepatitis C Virus Infection Sensitizes Human (2011) (0)
Frequency Responses Is Linked to Naïve-Precursor T Cell + Hepatitis C Virus-Specific CD 8 Immunodominance of HLA-A 2-Restricted (2011) (0)
Local ablation of hepatocellular carcinoma results in activation of dendritic cells and induction of tumor specific T cell responses (2003) (0)
Biosynthesis Neurotransmitters Steroid hormones Vitamins Metabolism Dietary components Bile salts Drugs Xenobiotics (2017) (0)
[Pancreatic and biliary tract tumors--diagnosis: ultrasonic diagnosis--endosonography]. (2000) (0)
HCV protein expression and HCV RNA is downregulated in JFH1 infected primary human hepatocytes by CD154 (2010) (0)
[Molecular biology: applications in hepato-gastroenterology]. (1993) (0)
726 EVALUATION OF THE IMPACT OF BARE-METAL STENT TIPS ON OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARINOMA (HCC) (2012) (0)
Environment and Lifestyle - Effects on Disorders of the Digestive Tract: Falk Symposium 176, Freiburg, October 2010 (2011) (0)
[New methods for demonstrating nucleic acids]. (2001) (0)
Fulminante Hepatitis nach autologer Stammzelltransplantation (2009) (0)
Inactivation of differential tumor suppressor genes in gastro-entero-pancreatic neuroendocrine tumors (2005) (0)
[Viral hepatitis: molecular diagnosis]. (1998) (0)
Generation of stable 3'-mRNA cleavage fragments induced by siRNA in cells with high-levels of duck hepatitis B virus replication. (2014) (0)
79 Induction of virus-neutralizing antibodies is associated with viral clearance in a single-source outbreak of hepatitis C (2006) (0)
54 Cellular binding and entry of hepatitis C virus pseudotypes and virus-like particles requires a different set of cellular co-receptors (2006) (0)
Advances in personalized gastroenterology and hepatology 2016 (2016) (0)
[Gallstones: natural course and complications]. (1992) (0)
P.039 The APOBEC3C protein induces massive guanosine to adenosine hypermutations in hepatitis B virus genomes (2006) (0)
[Sofosbuvir: alternative in hepatitis C infection?]. (2013) (0)
[Molecular diagnostic tools in gastroenterology]. (2002) (0)
Announcement and Erratum (1999) (0)
Prevalence of opportunistic infections in patients with inflammatory bowel disease (2008) (0)
Hepatocellular carcinoma (2011) (0)
[Whipple's disease: molecular biology--clinical aspects--therapy]. (1997) (0)
An investigation into a requirement for the p53 tumour suppressor in cell transformation by SV40 (2006) (0)
271 HIGH EXPRESSION OF DIPEPTIDYLPEPTIDASE IV (CD26) ON INTRAHEPATIC TH17 CELLS IN INFLAMMATORY LIVER DISEASES (2011) (0)
Workshop II: Molecular Analysis of Hepatitis B Virus Infection (1988) (0)
cme: Liver Masses (2007) (0)
[Nobel Prize 2008: Viruses are more than infectious agents]. (2008) (0)
Is non-alcoholic steatohepatitis caused by alcohol? (2020) (0)
Protection by HLA-B27 in HCV infection: role of virological and immunological factors (2008) (0)
Differentialtherapie der chronischen Hepatitis (1988) (0)
Locally produced peginterferon as an opportunity to treat HCV in low and mid-income countries. (2010) (0)
Liver and pancreas transplantation. (1989) (0)
[Hepatology. Molecular revolution]. (1999) (0)
Inhibition of duck hepatitis B virus replication by antisense deoxynucleotides (1991) (0)
HBV-HCV Coinfection: Insights from a Novel Model System (2008) (0)
[Systemic treatment for hepatocellular carcinoma]. (2003) (0)
Immuneresponse tosynthetic peptide analogues ofhepatitis B surface antigen specific fortheadeterminant (1982) (0)
Development of a non-replicative, single shot DNA-based vaccine expressing all hepatitis B viral antigens (2004) (0)
Analysis of HCV-specific CD8+ T-cell cytolytic effector functions and their contribution to antiviral efficacy using a novel immunological model (2010) (0)
[Nonsurgical therapy of hepatocellular carcinoma]. (2002) (0)
[Advances in oncology--pathogenesis and individualized therapy]. (2004) (0)
A Look to the Future: Gene Therapy in Liver Diseases (2010) (0)
Nucleic acid-based antiviral and gene therapy of chronic hepatitis B infection : Molecular biology, pathogenesis and clinics (1997) (0)
CD154 expression reveals the presence of dysfunctional virus-specific CD4+ T cells during chronic HCV infection (2008) (0)
Subject Index Vol. 19, 2001 (2002) (0)
["Medical futility": the doctor caught between the demands for and the limitations of treatment]. (2004) (0)
Nasopharyngeal cancer: a promising future (2012) (0)
Hepatitis-C-Therapie bei Drogenpatienten - Replik (2005) (0)
Advances in Personalized Medicine 2016 (2016) (0)
T-Cell Response to Hepatitis B and C Virus: Lessons from the Chimpanzee Model (2005) (0)
[Early diagnosis of hepatocellular carcinoma]. (1992) (0)
638 IFN-α TREATMENT OF HEPATITIS B VIRUS (HBV)-INFECTED PRIMARY HUMAN HEPATOCYTES LEADS TO A SPECIFIC REDUCTION OF HBV MRNA LEVELS (2010) (0)
208 ANALYSIS OF CD8+ T-CELL RESPONSES TO AFP, GLYPICAN-3, MAGE-A1 AND NY-ESO-1 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA REVEALS A CLEAR HIERARCHY AND IMMUNODOMINANCE (2011) (0)
[RNA interference as antiviral strategy]. (2008) (0)
[Polymerase chain reaction--principles and clinical relevance]. (1994) (0)
[Nobel prize for medicine, 1992]. (1992) (0)
[Diagnostic imaging and therapy of hepatocellular carcinoma]. (1997) (0)
Neundörfer Neurological manifestations of chronic hepatitis C (0)
792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
БИОЛОГИЧЕСКИЕ НАУКИ BIOLOGICAL SCIENCES (2017) (0)
[Gene therapy--basic principles]. (1995) (0)
c-Jun is not essential for hepatocyte proliferation and liver zonation following Apc (2012) (0)
Screening for Hepatitis C Virus (HCV) protein interactions by the use of intergenotypic replicon chimeras (2011) (0)
[Molecular biology in internal medicine. Report of the 24th Ludwig Heilmeyer Symposium of the Society for Progress in Internal Medicine]. (1997) (0)
Alcohol dehydrogenase 3∗1 genotype is associated with hepatocellular carcinoma in alcohol-induced liver cirrhosis (2003) (0)
Hepatocellular carcinoma: future perspectives (2008) (0)
EGFR reactivates telomerase in immortalized squamous epithelial cells through PI3K/AKT-mediated phosphorylation and transcriptional regulation via Hif-1α (2006) (0)
TIPS: Thrombogenicity and early shunt insufficiency in patients with preserved coagulation capacity — effect of heparin and stents (1995) (0)
[The patient as partner -- observations regarding a respectful relationship with sick people]. (2005) (0)
346 Tupaia hepatocytes but not nonparenchymal liver cells can extensively repopulate the livers of UPA/RAG-2 mice (2004) (0)
Parallel in vitro expansion of human hepatitis C virus specific FoxP3- effector memory and FoxP3+ regulatory CD8+ T cells on recognition of the same antigen (2007) (0)
[Suppressor T-cells: immunologic regulator cells and clinical perspectives]. (2004) (0)
Rekombinante DNA-Technologie in der Medizin (1987) (0)
89 Successful gene therapy of experimental hepatocellular carcinoma by AFP-specific DNA-vaccination combined with intratumoral cytokine expression (2004) (0)
Ex vivo analysis of HCV-specific CD8+ T cell antiviral efficacy using a novel immunological model (2011) (0)
Tyrosine kinase inhibitors in oncology - part 2 (2005) (0)
Strategies for Targeted Uptake of Antisense Oligonucleotides in Hepatocytes (1999) (0)
[Hepatitis B and C virus mutants--clinical relevance]. (1994) (0)
589 HEPATITIS C VIRUS REPLICATION SENSITIZES HUMAN HEPATOMA CELLS TO TRAIL-INDUCED APOPTOSIS (2008) (0)
Genetics in liver diseases : proceedings of the Falk Symposium 156 held in Freiburg, Germany, October 8-9, 2006 (2007) (0)
The contribution of genetic and epigenetic pathways in the molecular pathogenesis in neuroendocrine cancers of the gastro-entero-pancreatic system (2004) (0)
Liver cancer. (2005) (0)
Sa1780 Comprehensive T Helper Cell Profiling Reveals Concomitant Upregulation of Regulatory T Cells and TH17 Cells in Active Inflammatory Bowel Disease (2013) (0)
[Interferon in hepatitis B]. (1998) (0)
[Gene technology: its medical importance]. (1993) (0)
5-Aminosalicylic acid is not tubulotoxic in patients with inflammatory bowel disease — A prospective study (2000) (0)
Molecular diagnosis and gene therapy : proceedings of the 88th Falk Symposium (part III of the Basel Liver Week), held in Basel, Switzerland, October 22-23, 1995 (1996) (0)
Analysis of HLA-B27-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses in Acute Resolving Hepatitis (2005) (0)
[Pathology: pacemaker of advances in medicine]. (2013) (0)
Comprar Genetics in Liver Disease | Blum, H.E. | 9781402063923 | Springer (2007) (0)
[Gene therapy for liver diseases--facts or fiction]. (2005) (0)
[A global problem: chronic liver disease]. (2015) (0)
[The 1995 Nobel Prize for medicine]. (1995) (0)
[Implication of mutation of hepatitis C virus 1b interferon sensitivity determining region(NS5A aa 2209-2248) response to interferon alpha therapy in patients with chronic hepatitis C]. (1999) (0)
[Without cell death there is no life]. (2002) (0)
[Meaningful and meaningless hygienic measures in internal medicine]. (2001) (0)
[New hepatitis viruses. Molecular biology and clinical aspects]. (1996) (0)
Characterization of the putative polysaccharide gene cluster in multidrug-resistant E. faecium to develop a targeted therapy (vaccine) (2015) (0)
Persistence of Hepatitis C Virus Infection Despite the Presence of Cross-neutralizing Antibodies in a Single-Source Outbreak of Hepatitis C (2006) (0)
Mechanisms of Interferon Resistance (2007) (0)
[Predictive medicine - clinical genetics 2010]. (2010) (0)
Hammerhead Ribozyme-Mediated Cleavage of Hepatitis B Virus RNA (1998) (0)
P.169 Targeting of hepatitis C virus-heparan sulfate by human anti-viral antibodies (2006) (0)
[Intracellular antibodies: a new therapeutic concept for virus infections and neoplasms]. (1999) (0)
[Personalized medicine]. (2020) (0)
Hepatocellular Carcinoma - Update 2007 (2007) (0)
Contents Vol. 19, 2001 (2002) (0)
[Kaposi sarcoma: a virus-induced tumor?]. (1997) (0)
[Hepatology. New research results in its significance for the understanding of liver diseases]. (1991) (0)
Abstracts of the Scientific Meeting of the Bayliss & Starling Society. Guest Editor: Keith D. Buchanan, Belfast, Northern Ireland (1999) (0)
Two-years report of the research project: “Immunohistopathologic evaluation of choroidal neovascular membranes secondary to age-related macular degeneration” (2006) (0)
Hepatocellular carcinoma - Global burden and risk factors (2007) (0)
372 HIERARCHY OF INHIBITORY RECEPTOR EXPRESSION BY HEPATITIS B VIRUS (HBV)-SPECIFIC CD8+ T CELLS IN CHRONIC HBV INFECTION (2013) (0)
Hepatitis-B-Virusmutanten--klinische Bedeutung. [Hepatitis B virus mutants--clinical significance] (1997) (0)
In vivo transcomplementation of HBV replication competent nucleocapsids reduces the HBSAG induced liver injury in transgenic mice (2003) (0)
[Diagnosis of BSE and Creutzfeldt-Jakob disease]. (1996) (0)
Current state of nonsurgical therapies for cholangiocarcinoma REVIEW (2010) (0)
[Nobel Prize for Medicine 1999]. (1999) (0)
Images in clinical medicine: colocolic fistula. (1993) (0)
Full breadth analysis of AFP-specific CD8+ T cells in patients with hepatocellular carcinoma in the blood and in the liver (2008) (0)
337 CD40 LIGAND DOWNREGULATES HCV PROTEIN EXPRESSION IN JFH1 INFECTED PRIMARY HUMAN HEPATOCYTES (2009) (0)
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (cid:1) (2008) (0)
Hepatitis C Virus Infection Sensitizes Human Hepatocytes to TRAIL-Induced Apoptosis in a Caspase 9-Dependent Manner 1 (2008) (0)
Virus Replication Complexes Visualization of Functional Hepatitis C Nonstructural Protein 5A Allows Direct Insertion of Green Fluorescent Protein into (2014) (0)
[Current diagnosis of viral hepatitis]. (1995) (0)
[Value of manometry]. (2000) (0)
[Viral hepatitis A to E--diagnosis, clinical aspects and therapy]. (1994) (0)
Cellular Binding and Entry of Hepatitis C Virus Pseudotypes and Virus-like Particles Requires a Different Set of Cellular Co-receptors (2006) (0)
[Current therapy of esophageal varices hemorrhage]. (1995) (0)
[Recombinant DNA technology in medicine]. (1987) (0)
[The German Association for the Study of the Liver (GASL) in the German Journal of Gastroenterology]. (2004) (0)
Molecular medicine - Personalized medicine (2005) (0)
Impact of tumor markers in diagnosis of patients with hepatocellular carcinoma (HCC) and their clinicopathologic correlation: an interim analysis (2012) (0)
[Is scientific misconduct preventable? stem cell scandal 2014: study was faked]. (2015) (0)
S2045 Collagen XVII and Cathepsin B - Two Candidate Genes Influencing Migration, Invasion and Metastasis in Genetically Generated Oral-Esophageal Cancer Cells (2008) (0)
[Transgenic plants]. (2002) (0)
Methylation of the Estrogen receptor promoter in the development of gastric cancer (2008) (0)
[Gastroenterology and hepatology in its many aspects]. (2001) (0)
Role of the transcription factor c-Jun/AP–1 in response to β-Catenin signaling in the liver (2012) (0)
[Hepatitis B and C: biology and molecular diagnosis]. (1994) (0)
Fritz von Weizsäcker 1960-2019: An exceptional physician-scientist. (2020) (0)
DNA Chip-Technologie (2008) (0)
[Gene technology drugs and gene therapy]. (1999) (0)
[Colorectal cancer and inhibition of cyclooxygenase-2]. (2002) (0)
Evolving treatments of virus-associated HCC: new targets and drugs. (2010) (0)
Determinants of CD8+ T cell exhaustion during chronic hepatitis C virus infection (2010) (0)
[Hepatitis C-associated vasculitic mononeuritis multiplex]. (1997) (0)
Non-B, Non-C Viral Hepatitis (2020) (0)
[Chronic hepatitis. 1: Diagnosis]. (2001) (0)
P.183 HCV NS5A protein and response to IFN α: mutational analysis in 3a genotype chronic hepatitis C patients from India (2006) (0)
„6th Drug Development Seminar 2005 – Antiparasitic Chemotherapy“ (2006) (0)
286 DOMINANT CYTOLYTIC ANTIVIRAL EFFECTOR FUNCTIONS IN A NOVEL IMMUNOLOGICAL MODEL OF HBV INFECTION (2011) (0)
Cyclin D1 overexpression and p53 inactivation immortalizes primary oral keratinocytes by a telomerase independent mechanism (2001) (0)
HLA-A26 restricted HCV-specific CD8+ T cell responses in acute and chronic HCV infection (2006) (0)
[Gene therapy of hereditary liver diseases]. (2002) (0)
Global Elimination of Chronic Viral Hepatitis (2019) (0)
Presence and structure of HBV DNA in HBs-Ag-negative liver disease (1989) (0)
Impact of molecular biology in gastroenterology. (1993) (0)
Assessment of hepatic encephalopathy in 221 patients treated with the transjugular intrahepatic portosystemic stent shunt (TIPS) (2000) (0)
[Hepatocellular carcinoma: molecular biology aspects]. (1994) (0)
Hepatitis B Virus-Infected HepG2 hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efﬁcacy of CD8 (cid:2) T Cells In Vitro (2015) (0)
Characterization of candidate genes influencing migration, invasion and metastasis in genetically generated oral-esophageal cancer cells (2007) (0)
105 THE TRANSCRIPTION FACTOR C-JUN REGULATES HEPATOCYTE METABOLISM AND SURVIVAL IN RESPONSE TO β-CATENIN SIGNALING IN THE LIVER (2012) (0)
Regulatory T cells suppress virus-specific CD8+ T cells in chronically hepatitis C virus infected patients (2004) (0)
The patient as partner - clinical care respecting patient autonomy (2005) (0)
945 Central role of the hepatitis B virus X protein for the initiation of infection in primary hepatocytes (2003) (0)
Influence of type 2 diabetes mellitus on tumour characteristics and outcomes in patients with hepatocellular carcinoma (2013) (0)
EGFR-overexpression induces telomerase reactivation in immortalized oral epithelial cells by phosphorylation of the PI3K/AKT pathway (2005) (0)
Stent therapy in a patient with colorectal cancer stage IV (2011) (0)
The Microbiome in Liver Diseases (2020) (0)
Inhibition of Phosphodiesterase 5– a Novel Therapeutic Strategy for Portal Hypertension (2005) (0)
Duck hepatitis B virus (DHBV) infection: Detection of viral DNA and antigens in non-hepatocytes (1989) (0)
[Chronic liver disease--diagnostic work-up]. (2006) (0)
Detection of naïve hepatitis C virus-specific CD8+ T cells in chronically infected patients (2013) (0)
[Molecular biology of the hepatitis B virus: what is important for clinical medicine?]. (1986) (0)
Treatment of hepatocellular carcinoma. (2005) (0)
[Rheumatology today - a dynamic discipline for the patients' good]. (2011) (0)
Clinical and Economic Consequences of the Treatment of Postoperative Ileus with Alvimopan (2011) (0)
Molecular analysis of hepatitis B virus infection. (1988) (0)
Binding, Uptake and Presentation of Hepatitis C Virus-like Particles by Human Dendritic Cells: Implications for Vaccine Development (2004) (0)
[Diagnosis and treatment of hepatocellular carcinoma]. (2004) (0)
Identification and Characterization of Polysaccharide Biosynthesis Protein (CAPD) of Enterococcus faecium (2015) (0)
Phosphodiesterase-5 inhibitors decrease collateral blood flow in patients with portal hypertension (2008) (0)
Inhibition of differentiaton protein expression in advanced Biliary Tract Cancer (2009) (0)
[Stem cells--basic aspects and therapeutic perspectives]. (2007) (0)
Regulation of the hepatocellular response to endoplasmic reticulum stress by the transcription factor c-Jun/AP-1 (2011) (0)
941 REGULATION OF THE HEPATOCELLULAR RESPONSE TO ENDOPLASMIC RETICULUM STRESS BY THE TRANSCRIPTION FACTOR C-JUN/AP-1 (2010) (0)
[Chronic viral hepatitis: current diagnosis and therapy]. (1993) (0)
Functional Mapping of Hepatitis C Virus (HCV)-Dendritic Cell Interaction Using HCV-like Particles (2005) (0)
Expression profiling in a genetically defined mouse model of oral-esophageal dysplasia and cancer (2005) (0)
Cell therapies and regenerative medicine (2014) (0)
Chronic hepatitis C virus infection: a general indication for treatment! - Contra (2002) (0)
HLA-B*27 subtype specificity determines the targeting of HLA-B*27 restricted HCV-specific CD8+ T cell epitopes (2013) (0)
[The diagnosis of chronic hepatitis]. (2008) (0)
[Chronic hepatitis. 2: Treatment]. (2001) (0)
Virushepatitis@@@Viral hepatitis (2006) (0)
56 Scavenger receptor class B type i mediates uptake and cross-presentation of hepatitis C virus by human dendritic cells (2006) (0)
811 CD40 INHIBITS REPLICATION OF HEPATITIS C VIRUS BY JNK ACTIVATION INDEPENDENTLY OF THE INTERFERON PATHWAY (2011) (0)
[Guidelines for the therapy of hepatitis C]. (1996) (0)
Current Concepts of Chronicity and Immunity (0)
[Elevated liver enzymes]. (2010) (0)
T2010 ID Expression in Advanced Biliary Tract Cancer (2009) (0)
Clinical Significance of Molecular Studies of Hepatitis B Virus Infection (1987) (0)
New ways of interfering with HCV replication (2003) (0)
941 Reverse transcription of a non-viral RNA template by the human hepatitis B-virus polymerase (2003) (0)
Induction of anti-hepatitis B virus immune responses through DNA immunization. (2004) (0)
90 IMMUNODOMINANCE OF HLA-A*0201 RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL RESPONSES IS DETERMINED BY THE NAIVE PRECURSOR FREQUENCY (2011) (0)
The Membrane Anchor of GB virus B Nonstructural Protein 5B Can Substitute the Hepatitis C Virus NS5B Transmembrane Domain: Implications for a Conserved Protein Interaction Site (2010) (0)
Subject Index, Vol. 35, 1993 (1993) (0)
Percutaneous radiofrequency thermal ablation after occlusion of tumor draining vessels in the treatment of liver malignancies (2000) (0)
Characterization of immune responses against the hepatitis-B-virus (HBV) X-protein in mice (2003) (0)
[Current therapy for chronic viral hepatitis. The Viral Hepatitis Panel]. (1995) (0)
[Gene technology]. (1999) (0)
W1975 Genetic Inhibition of Telomerase Leads to Induction of ALT in Immortalized Human Esophageal Epithelial Cells and in Generated Human Squamous Cancer Cells (2008) (0)
Hepatitis B Virus Infection: Molecular Therapy and Prevention (1996) (0)
Solid-phase radioimmunoassay for hepatitis be antigen (HBeAg) (1979) (0)
[Gene therapy: medical and methodological aspects]. (1995) (0)
[Stimulus-triggered acquisition of pluripotency: a new perspective in reprogramming of differentiated somatic cells]. (2014) (0)
Analysis of Successful Virus-Specific CD8+ T Cell Responses in acute HBV infection (2006) (0)
1 Genetik (III) (2006) (0)
[Immunological T cell analyses -- current state and clinical relevance]. (2006) (0)
Duck hepatitis B virus: cloning and subcloning of the viral genome. (1989) (0)
M1990 Methylation of the Estrogen Receptor Promoter in the Development of Gastric Carcinoma (2009) (0)
Enhanced Replication ofaHepatitis B Virus Mutant Associated withanEpidemic ofFulminant Hepatitis (1994) (0)
Prognostic factors in 250 patients with refractory ascites treated with the transjugular intrahepatic portosystemic stent-shunt (TIPS) (2000) (0)
[Nobel Prize for Medicine 2003]. (2003) (0)
VIRAL FITNESS COST AND T CELL CROSS-RECOGNITION LIMIT VIRAL ESCAPE WITHIN A PROTECTIVE HLA-B27 RESTRICTED HEPATITIS C VIRUS SPECIFIC CD8+T CELL EPITOPE (2008) (0)
[Hepatitis A to E: current diagnosis]. (1992) (0)
No increase of the hemochromatosis gene in patients with chronic hepatitis C (1998) (0)
45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPE (2012) (0)
[Nobel Prize for Medicine 1993]. (1993) (0)
O.192 Scavenger receptor class B type I is a co-receptor for infection with cell culture-derived hepatitis C virus (2006) (0)
[Angiostatin. A biological inhibitor of tumor angiogenesis]. (1997) (0)
Genomics and Personalized Medicine (2020) (0)
[Therapy and prevention of esophageal varices hemorrhage: current status]. (1994) (0)
CD8+ T CELL RESPONSE IN ACUTE HCV INFECTION (2014) (0)
Binding of Hepatitis C Virus Envelope to Target Cells Induces a Cascade of Cell Signals Important for Antiviral Immune Responses and Lipid Metabolism (2004) (0)
25 Periphere Zirkulation (2006) (0)
Restoration of Hepatitis C virus-specific CD8+ T-cell responses in patients undergoing IFN-free antiviral therapy (2014) (0)
Hepatitis C Virus Replikation sensitiviert humane Hepatomazellen auf TRAIL-induzierte Apoptose (2008) (0)
[Spider naevi after discontinuation of oral contraceptives]. (1996) (0)
Hepatitis B Virus and Hepatocellular Carcinoma (1986) (0)
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report (2011) (0)
[Quorum sensing: a mechanism of communication between bacteria]. (1998) (0)
Inhibition of hepatitis B virus replication by antisense RNA (1995) (0)
Task difficulty influencing lateralization during pitch and duration discrimination in human subjects: an fMRI study (2006) (0)
Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A*□S (2004) (0)
Transformation of primary human oral squamous epithelial cells without ectopic activation of telomerase (2003) (0)
Differential Transcription regulation of human telomerase in a cellular model of esophageal squamous carcinogenesis (2003) (0)
[The fundamentals of gene technology]. (1993) (0)
[What contribution makes DNA sequencing in clinical practice? - before widespread application DNA sequencing has to be optimized]. (2014) (0)
Comprehensive analysis of the intrahepatic virus-specific CD8+ T-cell response during chronic hepatitis C virus infection (2004) (0)
[Principles and perspectives -- advances and future of medicine]. (2006) (0)
Regulatory T Cells Suppress Virus-Specific CD8+ T Cell Proliferation During Chronic Hepatitis C Virus Infection (2005) (0)
Prof. Dr. med. Dr. h. c. WalterSiegenthaler – 1923 – 2010 (2010) (0)
P603 DIFFERENCES IN THE HEPATOCYTE POLYPLOIDY CORRESPOND WITH DIFFERENCES IN INSULIN BINDING AND DIVERGING METABOLIC FUNCTIONS (2014) (0)
NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 100mM DPC) (2004) (0)
449 Hepatitis C virus structural proteins and activation of Toll-like receptors 2 and 4 (2006) (0)
Leonardo Complex Including a Candidate Viral Replication Induces Distinct Membrane Alterations Expression of Hepatitis C Virus Proteins (2002) (0)
Suppression of hepatocellular carcinoma growth by an activatible interferon regulatory factor-1 (IRF-1) (2001) (0)
Small hepatocellular carcinoma: Treatment with percutaneous radiofrequency thermal ablation (2000) (0)
Maintenance of virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154 (2009) (0)
[Hereditary hemochromatosis]. (1998) (0)
[Dolly, Polly et al.: cloning by somatic cell nucleus transfer]. (1999) (0)
Scavenger Receptor Class B Type I is a Hepatitis C Virus Receptor on Human Dendritic Cells (2006) (0)
[Molecular biology 1996: gastroenterology and hepatology]. (1997) (0)
O.173 Virus-host interactions during the first steps of viral infection: host cell responses induced by cellular binding of hepatitis C virus-like particles (2006) (0)
Malignant transformation of primary human oral squamous epithelial cells using a defined set of genetic alterations (2005) (0)
Cytokines and hepatitis C virus replication (2002) (0)
Current state of nonsurgical therapies for cholangiocarcinoma. (2014) (0)
Inhibition of interferon alpha signalling through the JAK-STAT pathway in HCV transgenic mice (2001) (0)
[Personalized medicine 2011]. (2011) (0)
Natural history of restricted synth virus genes in subacute sclerosing (2016) (0)
Genetic inhibition of telomerase induces alternative lengthening of telomeres (ALT) in genetically defined human esophageal epithelial cells (2008) (0)
EGFR-overexpression induces telomerase reactivation and cell cycle progression as distinct steps in a cellular model of oral esophageal carcinogenesis (2007) (0)
[The patient with hepatopathy]. (1997) (0)
[Prevention of hepatocellular carcinoma]. (2002) (0)
[Nonsurgical therapy of focal liver lesions]. (1997) (0)
Tupaia belangeri as a Model for Hepatitis C Virus Infection (2005) (0)
381 Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes in living cells (2003) (0)
[Transgenic plants--principle and medical relevance]. (2002) (0)
694 DIAGNOSTIC ACCURACY OF HCC BIOMARKERS DEPENDS ON THE ETIOLOGY OF LIVER DISEASE: AN INTERIM ANALYSIS (2012) (0)
40 HLA-B27 HAS A DOMINANT ROLE IN RESTRICTING STRONG CD8+ T CELL RESPONSES AND DRIVING VIRAL ESCAPE IN HEPATITIS B VIRUS INFECTION (2012) (0)
[Chronic hepatitis B: diagnostic value of hepatitis-B-virus DNA analysis in serum and liver tissue]. (1990) (0)
O12 RESTORATION OF HCV-SPECIFIC CD8+ T-CELL RESPONSES WITH INTERFERON-FREE TREATMENT OF HEPATITIS C (2014) (0)
[Cholestatic liver diseases]. (2004) (0)
Sofosbuvir: Alternative bei Hepatitis C? – Chronische Hepatitis C: Interferon-freie antivirale Strategien ante portas (2013) (0)
The microbiome: key player in human health and disease. Review article (2017) (0)
[Current diagnosis of viral hepatitis]. (1996) (0)
[The Nobel Prize for Medicine 1994]. (1994) (0)
[Clinical research in Germany--improvements are necessary and possible]. (2002) (0)
[Therapy of hepatitis C]. (2002) (0)
[Esophageal varices bleeding: causes and pathophysiology]. (1995) (0)
395 Intrahepatic CD8+ T cell failure: T cell dysfunction and viral escape during chronic HCV infection (2003) (0)
783 HBV-SPECIFIC CD8+ T CELLS AND NK CELLS MEDIATE THEIR ANTIVIRAL EFFECT PRIMARILY VIA PERFORIN/GRANZYME DEPENDENT CYTOLYSIS (2012) (0)
[Therapy of Crohn disease in internal medicine: postoperative recurrence and fistulas]. (1998) (0)
Long-term follow-up of posttransfusion and sporadic chronic non-A, non-B hepatitis (1989) (0)
A method for the prevention of viral replication (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Hubert Erich Blum?

Hubert Erich Blum is affiliated with the following schools: